Technology News and Research

RSS

Dalton Pharma expands pharmaceutical manufacturing services

Dalton Pharma Services is pleased to announce the expansion of its pharmaceutical manufacturing services by adding Formulation Development to its list of integrated capabilities.

22 Sep 2009

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world’s most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

22 Sep 2009

VeriChip granted exclusive license to virus triage detection system patents

VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the H1N1 virus.

21 Sep 2009

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

21 Sep 2009

Seniors worry about Democratic proposals as well as so-called myths spread by opponents

In response to Democratic health reform proposals, seniors are attending town halls, writing letters to lawmakers, showing support for the GOP in polls, and "giving their legislators a piece of their mind that a way of life is slipping away," The Washington Times reports.

21 Sep 2009

Cydex Pharmaceuticals announces extension of agreement with Hovione

CyDex Pharmaceuticals, Inc. today announced the extension of its relationship with Hovione SA as the company’s exclusive supplier of Captisol® for an additional five years.

21 Sep 2009

Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced the signing of a contract with Carpenter Technology Corporation (NYSE: CRS), wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive license from Manhattan Scientifics and the Los Alamos National Laboratory. The contract includes minimum annual payments to Manhattan Scientifics during a 4-year period, together with royalty payments as a percent of gross sales.

21 Sep 2009

Navicure adds two Minnesota-based organizations to its client roster

Navicure, a leading Internet-based medical claims clearinghouse for physician practices, today announced the addition of two Minnesota-based organizations to its client roster. Heartland Orthopedic Specialists and Fond du Lac Human Services both selected Navicure’s award-winning account receivables management solutions to improve claims management and increase profitability.

21 Sep 2009

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established, prestigious institution that has performed preclinical testing services for several vaccines and antivirals.

21 Sep 2009

Memorial Medical Center deploys Motorola's 802.11n WLAN solution to improve patient care

The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT), today announced that Lowry Computer, a leading systems integrator and Motorola channel partner, has deployed its 802.11n wireless LAN (WLAN) solution at Memorial Medical Center (MMC) of Western Michigan, a community hospital located in Ludington, Mich.

21 Sep 2009

Geron and Corning develop synthetic surface that supports the growth and differentiation of hESCs

Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).

21 Sep 2009

GE Capital deploys $1 billion in the U.S. healthcare market for the first six months of 2009

GE Capital’s Healthcare Financial Services business ended the first six months of 2009 as one of the most active capital providers in the U.S. healthcare market, deploying approximately $1 billion for more than 45 transactions. Loans were used to refinance existing debt, support working capital needs and fund growth initiatives.

21 Sep 2009

Phytel releases new version of its web-based Proactive Patient Outreach Solution

Phytel, the leading provider of information technology that empowers physician-led health improvement, today announced that version 5 of its web-based Proactive Patient Outreach Solution has been released and fully deployed to all of its customers.

21 Sep 2009

Primeradx raises funds for commercialization of their technology

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company’s existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.

21 Sep 2009

Maxygen completes joint venture transaction with Astellas Pharma

Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.

21 Sep 2009

Two new products released by Simbionix USA Corporation

Simbionix USA Corporation, the world's leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM).

21 Sep 2009

BRS Labs announces a video-surveillance technology that processes visual data like human brain

Behavioral Recognition Systems (BRS Labs) today announces a ground-breaking video-surveillance technology called Behavioral Analytics™, which leverages cognitive reasoning, and processes visual data on a level similar to the human brain.

21 Sep 2009

Study reveals that Europe must change perspectives towards food security

A new report by leading food and sustainability scientists calls for Europe to take a new approach on food security, prioritizing health and sustainability in research and using a holistic view when making policy. The report has been jointly chaired by Peter Raspor, professor of food science and technology at the University of Ljubljana, Slovenia and Rudy Rabbinge, professor of sustainable development and systems innovation at Wageningen University, the Netherlands.

21 Sep 2009

Sandia National Laboratories awards equipment contract to Arrayit Corporation

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences and nanotechnology technology leader, announces that on September 11th, 2009 Arrayit delivered its proprietary nanotechnology platform to Sandia National Laboratories in Albuquerque, New Mexico. Sandia Labs, managed by the Lockheed Martin Corporation, works with the Transportation Security Administration (TSA) and the Department of Homeland Security to enhance national security.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

Technology News and Research

Dalton Pharma expands pharmaceutical manufacturing services

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

VeriChip granted exclusive license to virus triage detection system patents

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

Seniors worry about Democratic proposals as well as so-called myths spread by opponents

Cydex Pharmaceuticals announces extension of agreement with Hovione

Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Navicure adds two Minnesota-based organizations to its client roster

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

Memorial Medical Center deploys Motorola's 802.11n WLAN solution to improve patient care

Geron and Corning develop synthetic surface that supports the growth and differentiation of hESCs

GE Capital deploys $1 billion in the U.S. healthcare market for the first six months of 2009

Phytel releases new version of its web-based Proactive Patient Outreach Solution

Primeradx raises funds for commercialization of their technology

Maxygen completes joint venture transaction with Astellas Pharma

Two new products released by Simbionix USA Corporation

BRS Labs announces a video-surveillance technology that processes visual data like human brain

Study reveals that Europe must change perspectives towards food security

Sandia National Laboratories awards equipment contract to Arrayit Corporation

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News